Special commentary: patient safety and the next generation of HPV DNA tests.
about
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerMethylation of HPV16 genome CpG sites is associated with cervix precancer and cancerAmerican Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.Human papillomavirus and cervical cancer: biomarkers for improved prevention effortsComparing the Cervista HPV HR test and Hybrid Capture 2 assay in a Dutch screening population: improved specificity of the Cervista HPV HR test by changing the cut-off.Evaluation of the Cobas 4800 HPV Test for Detecting High-Risk Human Papilloma-Virus in Cervical Cytology Specimens[Molecular diagnosis of HPV infections].Human papillomavirus testing in the prevention of cervical cancerHPV testing by cobas HPV test in a population from Catalonia.Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay.Clinical application of DNA ploidy to cervical cancer screening: A review.From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice.A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off.Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic reviewComparison of clinical and analytical performance of the Abbott Realtime High Risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening.Clinical experience with the Cervista HPV HR assay: correlation of cytology and HPV status from 56,501 specimensLaboratory and clinical aspects of human papillomavirus testingLimitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening.A modified Latent Class Model assessment of human papillomavirus-based screening tests for cervical lesions in women with atypical glandular cells: a Gynecologic Oncology Group studyProspective study of HPV16 viral load and risk of in situ and invasive squamous cervical cancer.Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping.Estimating the agreement and diagnostic accuracy of two diagnostic tests when one test is conducted on only a subsample of specimensSignificance of "Not Detected but Amplified" Results by Real-Time PCR Method for HPV DNA Detection.Commercially available assays for multiplex detection of alpha human papillomaviruses.Human papillomavirus testing and genotyping in cervical screening.Human papilloma virus (HPV) molecular diagnostics.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.Comparison of Three Different Commercial Kits for the Human Papilloma Virus Genotyping.Implications of semi-quantitative HPV viral load estimation by Hybrid capture 2 in colposcopy practice.Clinical laboratory experience with cervista HPV HR as a function of cytological classification: comparison with retrospective digene HC2 high-risk HPV DNA test data.Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening.American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
P2860
Q24607403-C33956CD-E144-4949-BFF4-9FA2BEEBB368Q24633086-3BD461A4-F35F-441B-B8AC-3379ED60B471Q26828840-9C2204B7-BF1D-4D5C-8D04-7026DCD92A28Q27023127-1A71F140-A7D7-44E4-BFE5-1321B07482DFQ33933176-E920A927-2CBB-4E3D-97E6-F60349E9E44AQ34533374-4D27555F-FC6C-46B9-A17D-D7B165EC126DQ34543310-924BDEE4-417D-40F1-A706-742D044A30D5Q34616083-87F291C6-E821-490E-834B-D9F8E9F4A954Q34618650-CE4D03F4-D1EE-4B28-944E-7245859D3A07Q34637954-23CCF229-5C1A-4E91-99AC-AAA44E4623F7Q34657755-AD31F317-75F0-4A20-A184-5D03E1D1D035Q34774870-8FD68E16-68A1-42D6-9D79-F9A91BDB9E97Q34789131-3BC535E1-8750-4EAC-9D32-5B39569171D1Q34997580-04D96F44-BE34-4863-B14A-F613F689B2E9Q35066533-18771810-B527-4569-8D01-C2441797E903Q35083587-BD36CF28-3194-4AC0-9197-932F2E51CFA8Q36311573-752E6FA2-C76D-4ABA-B7FE-C4B63BEB1FADQ36395656-5487F5BF-DD80-4334-958B-29BEF8FB204CQ36403718-55E0C113-50E7-4D8E-A018-525BA4987A02Q36514349-1DB7A78B-B3B0-44EB-A81E-54BD660A7C8BQ36530640-12CFAB11-D48D-48F5-8DA6-417DD3274638Q37259627-9D052ABA-B14B-41FB-8F8D-4792D05EE539Q37554027-E86BD80A-D7E1-4B73-931B-B84BE499774FQ37800921-B70B86C2-E6CB-4E5B-AC60-326C206B8F2EQ37909359-1B2D6138-5AA2-40E6-A9F2-4C994417A41EQ37923517-2AC563C0-55F5-49B1-8A9C-CDCE41D43B61Q38258014-7F01164F-4EE8-49C7-9F08-5A66B17F2795Q40481317-EFE9CC63-4A71-4DAB-8FDE-242AAD160418Q41124641-AC68C878-B0C7-485E-B066-7CF5D64839C2Q43233441-800AC1C1-78F7-4810-9FF1-977D17BF0B39Q52646463-E320CB21-6CED-4D9F-A854-9CF35A294FCAQ57089342-B8CB77A1-D0EC-4766-8DBB-294D739D40C4
P2860
Special commentary: patient safety and the next generation of HPV DNA tests.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Special commentary: patient safety and the next generation of HPV DNA tests.
@en
Special commentary: patient safety and the next generation of HPV DNA tests.
@nl
type
label
Special commentary: patient safety and the next generation of HPV DNA tests.
@en
Special commentary: patient safety and the next generation of HPV DNA tests.
@nl
prefLabel
Special commentary: patient safety and the next generation of HPV DNA tests.
@en
Special commentary: patient safety and the next generation of HPV DNA tests.
@nl
P2093
P2860
P356
P1476
Special commentary: patient safety and the next generation of HPV DNA tests.
@en
P2093
Mark H Stoler
Philip E Castle
Walter Kinney
P2860
P304
P356
10.1309/AJCPRI8XPQUEAA3K
P407
P577
2010-08-01T00:00:00Z